The BioMarker Solution
Research on aging is beginning to unlock the secrets underlying longevity. Our generation will be the first to benefit from scientific advances that directly extend a normal and healthy human lifespan. Currently, there are no authentic "anti-aging" pharmaceuticals or nutraceuticals since the aging component is often overlooked in conventional drug development, and under-validated in dietary supplement development. However, there is a strong a gene-related component to adult-onset diabetes, cancer, cardiovascular disease, Alzheimer's disease and other diseases commonly associated with aging.
BioMarker is using genomic and proteomic technologies to develop and deliver products for prolonging a healthy human lifespan.
BioMarker Pharmaceuticals is the first company to target product development by focusing on mechanisms underlying aging and age-related diseases. We use a suite of gene and protein expression analysis technologies to design and assess aging interventions. This includes our proprietary system for the design and development of products that mimic the effects of caloric restriction – to date, the only intervention known to consistently extend lifespan and retard aging in mammals.
We are using our aging-intervention technology portfolio to push forward in three areas:
-
In the nearest term, we are designing and evaluating dietary supplements for age-related health maintenance, and are moving forward immediately to bring products to market. By combining in vitro and animal aging-intervention evaluation with in vivo human clinical studies of traditional biomarkers of health (such as cholesterol, blood glucose, and weight measurements), we intend to be at the forefront in providing proven, scientifically and clinically validated health maintenance products;
-
In the intermediate term, we are designing risk assessment and diagnostic tools needed to provide people with personalized health-maintenance solutions.
Our nutrigenomic approach will allow us to monitor diet and gene interactions, assess and monitor individual responses to dietary supplements and other interventions, and provide personalized dietary guidelines and recommendations; and,
-
As aging-intervention technology matures, our screening systems will allow us to develop pharmaceutical products targeted to a variety of age-related diseases, and finally, to aging itself. Our final goal is to develop effective therapeutics that will allow people to maintain a very high level of health, vitality, and wellness, far into old age.
In short, our mission is for you to live better, longer. |
